Sygnature Discovery Limited
Tim R. Kendall is a seasoned professional in business development and licensing within the pharmaceutical and biotechnology sectors. Currently serving as Commercial Director and Non-Executive Director at LCC Therapeutics, Tim also holds positions as a Business Development Consultant at Rallybio and Managing Partner at J-BioVenture Partners. Tim's extensive experience includes roles at Sygnature Discovery, ConneKTia International, Interprotein Corporation, and others, focusing on bridging gaps between the EU/US and Japan, particularly in drug discovery and innovative medicines. Tim's educational background includes studies at Poynton County High School, Alliance Manchester Business School, and Kyoto University.
This person is not in any teams
This person is not in any offices
Sygnature Discovery Limited
2 followers
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.